New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 27, 2012
09:09 EDTPRANPrana completes recruitment in IMAGINE trial
Prana Biotechnology announced that it has completed recruitment in the IMAGINE trial, a 12 month Phase II trial testing PBT2, the Company's drug in development for Alzheimer's Disease. The double-blind placebo controlled trial has enrolled 41 patients with prodromal or mild Alzheimer's Disease in Melbourne, Australia. One additional patient may be included in the trial, subject to final screening procedures this week. All trial participants are undergoing brain scans to measure PBT2's effect on amyloid deposits in the brain and effects on increasing brain activity.
News For PRAN From The Last 14 Days
Check below for free stories on PRAN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 5, 2014
16:25 EDTPRANOn The Fly: Closing Wrap
Subscribe for More Information
10:28 EDTPRANHigh option volume stocks
Subscribe for More Information
September 4, 2014
18:50 EDTPRANPrana up 9.8% in after hours trading after receiving FDA orphan designation
Subscribe for More Information
18:06 EDTPRANPrana granted orphan status for treatment of Huntington disease
The FDA posted on its website that Prana Biotechnology has been granted orphan status for its treatment of Huntington's disease. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use